Spero Therapeutics SPRO
NASDAQ SPRO
$1.02 +0.01 (+0.99%)
At close: Nov 11, 2026 · 4:00 PM EST

Spero Therapeutics (SPRO) Tax Provisions (2023 - 2025)

Updated

Spero Therapeutics (SPRO) reported Tax Provisions of $261,000 for Q4 2025, compared with -$290,000 a year earlier.

Analysis

Spero Therapeutics (SPRO) Tax Provisions (2023 - 2025) Analysis & Trends

Dating back to Q3 2023, Spero Therapeutics' Tax Provisions record includes 5 quarters.

  • By year, Tax Provisions came in at $2.6 million in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Tax Provisions since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 1.96 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -176.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 609.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 492.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -842.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 822.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 634.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 134.00 Mn
10 Spero Therapeutics 58.73 Mn -137.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 261,000.00
Dec 31, 2024 -290,000.00
Sep 30, 2024 290,000.00
Dec 31, 2023 387,000.00
Sep 30, 2023 2.21 Mn
API Access

Spero Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=SPRO&period=max&api_key=YOUR_API_KEY